lactic acidosis: Metabolic disease characterized by the accumulation of lactate in the body. It is caused by tissue hypoxia
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
688 |
4. Check minimum number of eventsNone |
688 |
5. Include endpointsNone |
688 |
6. Filter based on genotype QC (FinnGen only) |
688 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E87
- Name in latin
- Acidosis
Similar endpoints
↥List of similar endpoints to
Acidosis
based on the number of shared cases.
Similar with more cases:
- Other disorders of fluid, electrolyte and acid-base balance
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5856 | 2122 | 3700 |
| Only index persons | 5240 | 1915 | 3325 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.06 | 0.10 |
| Only index persons | 0.11 | 0.07 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 65.37 | 68.63 | 63.47 |
| Only index persons | 65.67 | 68.69 | 63.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 688 | 240 | 448 |
| Unadjusted period prevalence (%) | 0.16 | 0.08 | 0.20 |
| Median age at first event (years) | 64.91 | 63.72 | 65.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 610
- Matched controls
- 6100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E87.2
ICD-10 Finland
Acidosis
+∞
323.0
607
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
45.0
156.2
193
62
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
8.8
125.9
356
838
103
Kela drug reimbursment
Diabetes, insulin-treated
8.0
119.5
378
1031
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
9.1
113.4
288
547
A10BA02
ATC
metformin; oral
7.3
110.0
375
1095
215
Kela drug reimbursment
Diabetes, non-insulin-treated
7.0
101.9
335
901
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
13.3
97.5
183
190
T90
ICPC
Diabetes non-insulin dependent
6.4
90.9
312
853
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
10.5
89.8
193
258
A10AE04
ATC
insulin glargine; parenteral
9.7
83.8
188
268
E86
ICD-10 Finland
Volume depletion
236.3
81.5
82
*
A10BH01
ATC
sitagliptin; oral
8.4
78.3
193
318
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
155.3
78.1
81
6
C03CA01
ATC
furosemide; systemic
5.2
75.8
324
1084
E87.5
ICD-10 Finland
Hyperkalaemia
140.0
70.6
74
6
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
9.8
66.4
144
186
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.6
60.1
206
508
A10BB12
ATC
glimepiride; oral
7.7
55.1
139
225
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.8
55.1
118
146
C07AB07
ATC
bisoprolol; oral
3.8
52.2
398
2026
F10.25
ICD-10 Finland
Alcohol dependence continuous use
20.5
52.2
79
44
AA1AD
NOMESCO Finland
CT of head and brain
4.2
51.3
251
871
TK800
NOMESCO Finland
Hemodialysis
18.6
51.2
80
49
E87.6
ICD-10 Finland
Hypokalaemia
33.9
49.1
64
21
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
48.5
168
406
I10
ICD-10 Finland
Essential (primary) hypertension
3.7
46.6
453
2683
SPAT1262
SPAT
Handing over of treatment supplies
4.2
45.0
205
650
N17.8
ICD-10 Finland
Other acute renal failure
43.0
44.6
55
14
A10AE05
ATC
insulin detemir; parenteral
9.3
44.4
97
122
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
41.3
139
319
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
8.4
41.1
95
131
205
Kela drug reimbursment
Chronic hypertension
3.4
40.8
274
1180
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
39.9
353
1845
A10BH05
ATC
linagliptin; oral
8.7
38.7
87
114
T36
ICD-10 Finland
Poisoning by systemic antibiotics
10.1
38.0
78
87
JN3AD
NOMESCO Finland
Abdominal CT examination
5.9
37.0
111
220
N18.8
ICD-10 Finland
Other chronic renal failure
13.1
36.3
65
55
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6.4
35.9
101
184
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
11.3
35.9
69
68
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
11.0
35.8
70
71
I50.9
ICD-10 Finland
Heart failure, unspecified
4.3
35.6
151
435
E11
ICD-10 Finland
Type 2 diabetes mellitus
3.9
35.4
173
566
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.6
34.6
135
358
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
34.1
239
1029
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
34.1
128
326
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
25.3
33.7
47
20
F10.09
ICD-10 Finland
Alcohol intoxication UNS
13.5
33.5
59
48
R11
ICD-10 Finland
Nausea and vomiting
6.2
33.4
95
175
WX872
NOMESCO Finland
Intensive care
7.1
32.8
84
134
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
32.5
216
890
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
32.2
253
1167
N07BB01
ATC
disulfiram; oral
7.4
32.2
80
122
N05AH04
ATC
quetiapine; oral
4.0
32.0
148
457
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.3
31.9
90
164
N19
ICD-10 Finland
Unspecified kidney failure
10.5
31.7
63
66
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.0
31.4
61
61
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
4.4
30.8
125
341
A41.9
ICD-10 Finland
Sepsis, unspecified
8.6
30.4
68
88
C08CA01
ATC
amlodipine; oral
2.8
30.0
288
1492
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
13.8
29.4
51
40
M04AA01
ATC
allopurinol; systemic
3.7
29.1
146
480
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.6
28.9
149
500
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.9
28.9
234
1083
F10.24
ICD-10 Finland
Alcohol depence active use
16.7
28.1
45
29
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
17.5
28.0
44
27
TK810
NOMESCO Finland
Hemofiltration
37.0
27.7
35
10
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
12.0
27.6
51
46
C03DA01
ATC
spironolactone; oral
4.2
27.4
114
316
A28
ICPC
Limited function/disability NOS
3.4
26.9
147
514
R53
ICD-10 Finland
Malaise and fatigue
3.1
26.4
170
667
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
14.2
26.4
45
34
N06AX11
ATC
mirtazapine; oral
2.7
26.4
232
1117
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
25.9
114
332
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.1
25.9
86
189
C10AA01
ATC
simvastatin; oral
2.5
25.7
316
1828
TKC20
NOMESCO Finland
Catheterisation of bladder
4.7
25.4
92
222
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
13.5
25.3
44
35
WX892
NOMESCO Finland
Monitored bed care
4.5
25.0
95
241
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
12.7
24.6
44
37
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
6.2
23.7
66
117
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
20.6
23.7
35
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
23.4
98
272
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.0
23.2
100
285
WX730
NOMESCO Finland
Conventional respirator
12.8
23.1
41
34
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
6.5
22.9
61
102
I50.0
ICD-10 Finland
Congestive heart failure
4.8
22.9
81
190
A10BK03
ATC
empagliflozin; oral
4.7
22.9
82
195
P15
ICPC
Chronic alcohol abuse
7.6
22.7
54
77
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
22.2
78
182
L28
ICPC
Limited function/disability (L)
3.1
22.1
138
523
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
10.9
21.4
41
40
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
20.9
108
356
T89
ICPC
Diabetes insulin dependent
7.9
20.8
48
65
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
43.3
20.6
25
6
G72.8
ICD-10 Finland
Other specified myopathies
12.2
20.5
37
32
F10.20
ICD-10 Finland
Alcohol dependence currently independent
9.2
20.5
43
50
WX882
NOMESCO Finland
High dependency care
7.7
20.4
48
67
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.6
20.4
174
799
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
20.2
170
774
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
16.0
19.9
32
21
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
19.9
66
144
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
19.9
85
239
K92.0
ICD-10 Finland
Haematemesis
8.6
19.8
43
53
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
19.6
219
1161
N05BA01
ATC
diazepam; systemic, rectal
3.1
19.6
118
435
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
12.3
19.5
35
30
C09AA05
ATC
ramipril; oral
2.4
19.5
200
1014
N05CF01
ATC
zopiclone; oral
2.3
19.4
230
1251
XCK10
NOMESCO Finland
Photography of fundus of eye
3.5
19.1
97
315
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
6.3
18.9
51
87
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
9.6
18.6
38
42
P16
ICPC
Acute alcohol abuse
10.9
18.4
35
34
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
26.0
18.3
25
10
A02BC02
ATC
pantoprazole; systemic
2.2
18.3
410
2952
A06AD11
ATC
lactulose; oral
2.9
18.2
121
473
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
12.4
18.0
32
27
SPAT1254
SPAT
Administration of medicine
2.9
17.9
124
500
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.8
17.7
45
71
M10.9
ICD-10 Finland
Gout, unspecified
4.0
17.7
74
204
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
16.2
17.6
28
18
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.0
17.5
57
122
A46
ICD-10 Finland
Erysipelas
2.8
17.4
121
488
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
17.4
162
774
C09AA02
ATC
enalapril; systemic
2.5
17.2
159
755
K29.2
ICD-10 Finland
Alcoholic gastritis
51.6
17.1
20
*
JAH00
NOMESCO Finland
Laparotomy
6.6
17.0
44
71
Z49.1
ICD-10 Finland
Extracorporeal dialysis
11.6
16.9
31
28
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.3
16.9
183
942
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.5
16.8
50
97
N05BA04
ATC
oxazepam; oral
2.4
16.7
168
833
A10AE06
ATC
insulin degludec; parenteral
7.9
16.7
38
51
ZX120
NOMESCO Finland
Intravenous
3.4
16.7
85
276
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.9
16.5
55
121
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.4
16.5
36
45
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
16.4
139
626
A10BJ06
ATC
semaglutide; parenteral
6.6
16.2
42
68
R06.0
ICD-10 Finland
Dyspnoea
2.3
15.9
173
887
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
17.8
15.7
24
14
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
17.8
15.7
24
14
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
15.6
122
523
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
14.2
15.6
26
19
E66.00
ICD-10 Finland
Metabolic syndrome
4.8
15.6
53
119
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
15.5
117
494
J96.0
ICD-10 Finland
Acute respiratory failure
11.7
15.4
28
25
A11CC03
ATC
alfacalcidol; systemic
7.8
15.4
35
47
A10BG03
ATC
pioglitazone; oral
7.1
15.2
37
55
N05BA02
ATC
chlordiazepoxide; systemic
6.0
14.9
41
72
C10AA05
ATC
atorvastatin; oral
2.0
14.8
255
1593
A12BA01
ATC
potassium chloride; oral
4.7
14.7
51
117
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
8.4
14.7
32
40
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.2
14.5
82
286
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
8.5
14.4
31
38
A10BD07
ATC
metformin and sitagliptin; systemic
4.5
14.3
51
121
N05AH03
ATC
olanzapine; systemic
4.3
14.2
53
131
B03XA02
ATC
darbepoetin alfa; parenteral
8.3
14.2
31
39
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.5
14.2
33
46
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
6.4
14.2
37
61
K70.1
ICD-10 Finland
Alcoholic hepatitis
14.9
14.2
23
16
N05CD07
ATC
temazepam; oral
2.7
14.2
105
435
B03BA03
ATC
hydroxocobalamin; parenteral
3.7
14.0
62
179
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.6
13.8
64
192
N05AA02
ATC
levomepromazine; systemic
4.7
13.8
47
106
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
7.2
13.8
33
48
N06AX16
ATC
venlafaxine; oral
2.9
13.7
87
329
N02AA05
ATC
oxycodone; systemic
2.5
13.5
116
523
E66.01
ICD-10 Finland
Obesity due to excess calories
3.9
13.5
56
153
N06AB10
ATC
escitalopram; oral
2.5
13.5
120
550
K70.4
ICD-10 Finland
Alcoholic hepatic failure
26.4
13.4
18
7
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
5.4
13.4
40
78
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
6.1
13.4
36
62
SPAT1229
SPAT
Assessment of need for aid
3.3
13.1
69
229
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
13.1
99
414
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
17.2
13.1
20
12
N02AX02
ATC
tramadol; systemic, rectal
1.9
13.0
269
1773
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.8
13.0
32
49
A04
ICPC
Weakness/tiredness general
2.8
12.7
86
338
S06.0
ICD-10 Finland
Concussion
3.0
12.6
77
283
S97
ICPC
Chronic ulcer skin
3.8
12.6
54
152
E83.51
ICD-10 Finland
Hypocalcemia
+∞
12.5
12
*
C07AB02
ATC
metoprolol; systemic
2.2
12.5
148
779
B01AC04
ATC
clopidogrel; oral
2.5
12.5
109
492
177
Kela drug reimbursment
Insulin glargine 300 U / ml
8.7
12.4
26
31
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
9.9
12.3
24
25
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
12.3
127
628
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
12.3
64
211
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
12.2
73
262
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
8.0
12.2
27
35
N06AB04
ATC
citalopram; systemic
2.2
12.2
138
711
UJF32
NOMESCO Finland
Coloscopy
2.1
12.2
175
997
C02AC05
ATC
moxonidine; oral
4.4
12.1
44
107
R33
ICD-10 Finland
Retention of urine
3.0
12.0
73
267
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
12.0
122
597
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.3
11.9
28
40
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.5
11.8
55
166
A10BB01
ATC
glibenclamide; oral
4.0
11.7
47
125
B01AA03
ATC
warfarin; systemic
2.1
11.7
155
853
AN1
HP
Coronary angiography
2.6
11.7
91
386
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
5.9
11.6
32
57
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.0
11.6
70
254
R40.2
ICD-10 Finland
Coma, unspecified
14.0
11.5
19
14
JN4AD
NOMESCO Finland
Body CT examination
3.0
11.4
69
251
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
12.1
11.4
20
17
I50.1
ICD-10 Finland
Left ventricular failure
4.5
11.4
40
94
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.6
11.3
39
90
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.0
11.3
27
40
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
11.2
116
572
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.2
11.1
123
625
A10BJ02
ATC
liraglutide; parenteral
5.9
11.0
30
53
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.1
11.0
34
70
J01DB01
ATC
cefalexin; oral
2.0
10.9
488
4089
K70.0
ICD-10 Finland
Alcoholic fatty liver
10.8
10.8
20
19
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.4
10.8
38
90
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
28.6
10.8
14
5
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.7
10.7
30
55
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
10.6
83
355
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.1
10.6
142
783
N05AX08
ATC
risperidone; systemic
3.1
10.6
60
210
F05.9
ICD-10 Finland
Delirium, unspecified
6.1
10.5
28
48
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
10.5
84
360
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
10.5
145
807
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
10.5
204
1290
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
7.0
10.5
25
37
J01MA12
ATC
levofloxacin; systemic
2.1
10.5
130
691
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.9
10.4
33
70
S01.0
ICD-10 Finland
Open wound of scalp
2.8
10.3
68
263
N03AG01
ATC
valproic acid; systemic, rectal
3.4
10.3
50
157
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
7.7
10.3
23
31
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
4.0
10.2
40
105
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
10.2
130
698
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.2
10.1
108
536
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.2
10.1
53
176
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.7
10.1
21
25
J01MA02
ATC
ciprofloxacin; systemic
1.8
10.1
242
1640
J01FF01
ATC
clindamycin; systemic
1.9
10.1
165
979
K85
ICD-10 Finland
Acute pancreatitis
7.4
10.1
23
32
K56.7
ICD-10 Finland
Ileus, unspecified
7.4
10.1
23
32
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.1
10.0
38
97
D10
ICPC
Vomiting
3.9
9.9
40
108
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.0
9.9
39
103
C09CA01
ATC
losartan; oral
1.9
9.9
162
963
T51.0
ICD-10 Finland
Toxic effect: Ethanol
26.5
9.8
13
5
N02BE01
ATC
paracetamol; systemic, rectal
2.0
9.8
504
4321
E16.19
ICD-10 Finland
Other specified hypoglycaemia
20.4
9.8
14
7
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
5.3
9.8
29
57
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
6.7
9.8
24
37
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.2
9.8
36
89
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
9.8
62
234
V03AA01
ATC
NA
5.7
9.8
27
49
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
9.7
55
192
SPAT1216
SPAT
Assessment of functional ability
2.2
9.7
107
540
207
Kela drug reimbursment
Chronic arrhythmias
2.2
9.6
107
543
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.0
9.6
56
201
V03AE01
ATC
polystyrene sulfonate; oral
10.3
9.6
18
18
Y94.0
ICD-10 Finland
Accident at home
6.8
9.5
23
35
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.3
9.5
28
55
SPAT1125
SPAT
Stoma care and guidance
7.7
9.5
21
28
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
30.5
9.4
12
*
A02BC01
ATC
omeprazole; systemic
1.9
9.4
175
1083
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
9.4
77
336
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
3.8
9.3
38
104
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
9.3
186
1183
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.3
9.2
45
142
F34.1
ICD-10 Finland
Dysthymia
4.9
9.1
29
62
N06AA12
ATC
doxepin; systemic
3.3
9.1
46
149
K08.3
ICD-10 Finland
Retained dental root
2.9
9.1
54
196
B01AB05
ATC
enoxaparin; parenteral
1.8
9.1
186
1188
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.2
9.1
18
20
5CM18
NOMESCO Finland
NA
15.9
9.1
14
9
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.3
9.0
44
139
EBA30
NOMESCO Finland
Excision of root of tooth
3.2
9.0
46
151
W19
ICD-10 Finland
Unspecified fall
2.6
9.0
67
279
WX704
NOMESCO Finland
Intubation
2.9
9.0
53
192
JFB00
NOMESCO Finland
Partial resection of small intestine
7.0
8.9
21
31
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
7.0
8.9
21
31
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
8.7
73
321
A10BK01
ATC
dapagliflozin; oral
3.4
8.7
41
127
R50.9
ICD-10 Finland
Fever, unspecified
2.2
8.6
94
473
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.8
8.6
54
203
N06AX03
ATC
mianserin; oral
3.4
8.6
41
128
T68
ICD-10 Finland
Hypothermia
16.6
8.6
13
8
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
8.6
34
91
B01AB10
ATC
tinzaparin; parenteral
2.9
8.6
53
196
UJD02
NOMESCO Finland
Gastroscopy
3.2
8.5
44
146
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
8.2
51
188
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
7.7
8.2
18
24
I95.9
ICD-10 Finland
Hypotension, unspecified
7.7
8.2
18
24
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.0
8.2
31
80
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
8.1
65
281
H36.01
ICD-10 Finland
Diabetic maculopathy
8.3
8.1
17
21
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
7.0
8.1
19
28
A10BG02
ATC
rosiglitazone; oral
7.0
8.1
19
28
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
17.5
8.1
12
7
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
9.1
8.1
16
18
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
8.0
94
485
WX722
NOMESCO Finland
PEEP
3.1
8.0
42
141
N06AA09
ATC
amitriptyline; systemic
2.5
8.0
64
277
N03AX16
ATC
pregabalin; oral
1.9
7.9
139
837
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.3
7.9
23
45
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.9
7.9
31
83
C08CA13
ATC
lercanidipine; oral
2.2
7.9
85
426
SPAT1301
SPAT
No procedures
1.7
7.8
192
1286
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.0
7.8
14
13
EBA00
NOMESCO Finland
Extraction of tooth
1.7
7.8
192
1289
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
9.6
7.8
15
16
H25.1
ICD-10 Finland
Senile nuclear cataract
1.8
7.8
158
1000
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.4
7.8
22
42
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.3
7.8
37
116
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
7.7
60
256
NF1AA
NOMESCO Finland
Hip X-ray examination
2.5
7.7
60
257
S76
ICPC
Skin infection other
3.2
7.7
39
128
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.8
7.6
18
27
J01MA14
ATC
moxifloxacin; systemic
2.4
7.6
64
283
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.9
7.6
44
157
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
7.6
224
1580
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.5
7.6
61
263
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
25.4
7.6
10
*
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
25.4
7.6
10
*
N03AF01
ATC
carbamazepine; oral, rectal
3.0
7.5
43
152
SPAT1255
SPAT
Intravenous administration of medicine
2.8
7.5
47
175
SPAT1263
SPAT
Sampling
1.6
7.5
239
1720
P76
ICPC
Depressive disorder
3.6
7.5
32
92
N06AB03
ATC
fluoxetine; oral
2.2
7.5
73
348
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.6
7.5
54
220
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.6
7.5
18
28
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
81.0
7.4
8
*
JFF13
NOMESCO Finland
Terminal enterostomy
81.0
7.4
8
*
E13.1
ICD-10 Finland
Other specified diabetes mellitus, with ketoacidosis
81.0
7.4
8
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.9
7.4
43
154
H36.00
ICD-10 Finland
Diabetic background retinopathy
7.8
7.4
16
21
J96.1
ICD-10 Finland
Chronic respiratory failure
4.8
7.4
23
49
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
3.3
7.4
36
115
B81
ICPC
Anaemia vit B12/folate deficiency
3.3
7.4
36
115
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.9
7.4
29
78
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
8.5
7.4
15
18
N30.9
ICD-10 Finland
Cystitis, unspecified
3.5
7.4
33
99
R55
ICD-10 Finland
Syncope and collapse
2.2
7.3
72
343
A07AA09
ATC
vancomycin; oral
7.0
7.3
17
25
C03AA03
ATC
hydrochlorothiazide; oral
2.3
7.3
68
318
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
9.5
7.3
14
15
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.5
7.3
14
15
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
+∞
7.3
7
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.4
7.3
34
105
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.4
7.3
18
29
H04AA01
ATC
glucagon; nasal, parenteral
5.6
7.3
20
37
C09BA02
ATC
enalapril and diuretics; systemic
2.5
7.3
57
245
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
7.4
7.2
16
22
K92.1
ICD-10 Finland
Melaena
3.0
7.2
41
144
I20.00
ICD-10 Finland
Unstable angina
4.5
7.2
24
55
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
7.2
84
431
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.1
7.2
88
461
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
7.2
84
434
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.1
7.2
21
42
E83.50
ICD-10 Finland
Hypercalcemia
30.4
7.2
9
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.4
7.1
24
56
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
7.1
259
1924
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.1
159
1032
C01DA14
ATC
isosorbide mononitrate; oral
2.0
7.1
93
502
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
10.2
7.1
13
13
137
Kela drug reimbursment
Uraemia requiring dialysis
10.2
7.1
13
13
R60.0
ICD-10 Finland
Localized oedema
2.2
7.1
70
335
H02AB09
ATC
hydrocortisone; systemic
5.0
7.0
21
43
SPAT1211
SPAT
Application of soft bandage
2.4
7.0
60
267
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.7
7.0
29
82
A12AA04
ATC
calcium carbonate; oral
5.9
7.0
18
31
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
14.0
6.9
11
8
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.7
6.9
28
78
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.1
6.9
20
40
I25.2
ICD-10 Finland
Old myocardial infarction
2.6
6.8
48
194
SPAT1252
SPAT
Overall medication plan or its review
2.5
6.8
51
213
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
11.1
6.8
12
11
NGJ60
NOMESCO Finland
Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified
11.1
6.8
12
11
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.2
6.8
17
28
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
40.5
6.8
8
*
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
40.5
6.8
8
*
SPAT1247
SPAT
Outpatient detoxication and monitoring
16.9
6.8
10
6
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
6.7
40
147
A02BC03
ATC
lansoprazole; oral
1.7
6.7
164
1092
GD2SN
NOMESCO Finland
Lung ventilation SPECT
22.8
6.7
9
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
22.8
6.7
9
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
6.5
6.7
16
25
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
6.0
6.6
17
29
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
6.0
6.6
17
29
Z72.0
ICD-10 Finland
Tobacco use
4.7
6.6
21
46
SPAT1279
SPAT
Preparation of immediate hospitalisation
7.9
6.6
14
18
R4110
NOMESCO Finland
Physiotherapy
1.7
6.6
152
994
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.9
6.6
20
42
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
8.8
6.6
13
15
SPAT1234
SPAT
Support of social functional capacity
3.0
6.5
37
130
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.4
6.5
18
34
N05AB01
ATC
dixyrazine; systemic
6.3
6.5
16
26
XG466
NOMESCO Finland
Sleep oxymetry
3.5
6.5
28
82
E66.9
ICD-10 Finland
Obesity, unspecified
4.2
6.5
23
57
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
70.6
6.4
7
*
H02AB06
ATC
prednisolone; systemic
1.6
6.4
266
2027
Z94.0
ICD-10 Finland
Kidney transplant status
6.7
6.4
15
23
L04AX01
ATC
azathioprine; systemic
3.2
6.4
31
100
N05BA06
ATC
lorazepam; systemic, sublingual
3.0
6.4
36
126
H3601, E113
ICD-10 Finland
NA
5.3
6.4
18
35
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
6.3
23
58
A10AA02
ATC
NA
3.9
6.3
24
63
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
6.1
6.3
16
27
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.3
6.3
30
95
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
6.3
178
1231
E87.8
ICD-10 Finland
Other disorders of electrolyte and fluid balance, not elsewhere classified
+∞
6.3
6
*
T30
ICPC
Metabolic, Medical examin/health eval complete
+∞
6.3
6
*
M10.0
ICD-10 Finland
Idiopathic gout
3.7
6.3
25
69
A10AB06
ATC
insulin glulisine; parenteral
7.1
6.2
14
20
P99
ICPC
Psychological disorders other
4.6
6.2
20
45
Z72.1
ICD-10 Finland
Alcohol use
5.4
6.2
17
32
SPAT1260
SPAT
Consultation of another employee
1.8
6.2
107
637
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
5.8
6.2
16
28
S82.2
ICD-10 Finland
Fracture of shaft of tibia
5.8
6.2
16
28
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.1
6.1
22
55
C09AA03
ATC
lisinopril; oral
2.8
6.1
37
138
C07AG02
ATC
carvedilol; oral
2.5
6.1
44
182
SPAT1227
SPAT
Substance abuse rehabilitation
10.2
6.1
11
11
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.0
269
2072
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.3
6.0
17
33
R31
ICD-10 Finland
Unspecified haematuria
2.0
6.0
74
390
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.0
6.0
32
110
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
298
445
11.05
208.94
11.6
6.7
mmol/l
12.6
9.7
6.86
285
425
(3003458) Phosphate [Moles/volume] in Serum or Plasma
338
661
9.09
185.95
10.4
5.4
mmol/l
1.1
1.0
1.92
317
609
(3023183) Ammonium ion [Moles/volume] in Plasma
141
115
15.16
147.50
4.4
3.1
umol/l
39.3
35.2
0.69
127
100
(3012095) Magnesium [Moles/volume] in Serum or Plasma
334
822
6.95
141.46
6.0
3.5
mmol/l
0.8
0.8
13.42
314
772
(3020191) Ethanol [Moles/volume] in Serum or Plasma
82
29
31.97
123.98
2.2
1.1
promille
1.2
1.2
0.00
66
21
(3021447) Carbon dioxide [Partial pressure] in Venous blood
234
468
7.06
120.25
9.4
3.9
kpa
5.6
5.8
1.44
227
453
(3002032) Base excess in Venous blood by calculation
232
469
6.95
117.74
9.5
3.9
mmol/l
0.8
2.1
2.71
191
365
(3023368) Bacteria identified in Blood by Culture
424
1530
5.62
111.03
6.6
4.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
224
469
6.60
108.96
11.3
6.7
mmol/l
2.2
1.4
3.96
214
450
(3003396) Base excess in Arterial blood by calculation
245
629
5.50
94.00
13.0
7.2
mmol/l
-0.7
1.2
3.15
173
472
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
243
634
5.38
91.19
13.2
7.1
kpa
4.5
5.1
7.37
230
604
(3027801) Oxygen [Partial pressure] in Arterial blood
243
634
5.38
91.19
13.1
7.1
kpa
11.7
12.1
0.68
228
605
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
144
232
7.59
89.28
10.5
5.0
mmol/l
21.9
24.2
5.19
131
206
(3024354) Oxygen [Partial pressure] in Venous blood
190
412
5.99
87.53
7.3
3.3
kpa
4.7
4.5
0.40
183
400
(3000991) Gas panel - Venous blood
192
421
5.94
87.38
16.3
8.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
224
571
5.33
85.85
13.5
7.5
%
95.6
95.4
0.17
217
551
(1616796) Gas panel - Central venous blood
92
102
10.26
77.21
7.7
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
165
370
5.55
72.30
2.4
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
244
753
4.47
72.28
4.1
2.3
g/l
2.2
2.3
2.69
230
705
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
196
510
4.98
72.14
2.7
2.4
g/l
0.2
0.2
1.02
175
475
(3009343) pH of Capillary blood
166
380
5.44
70.98
7.6
3.6
ph
7.4
7.4
0.42
34
48
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
161
363
5.48
69.97
7.5
3.7
mmol/l
0.5
1.7
1.98
120
281
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
166
386
5.35
69.63
7.6
3.6
kpa
4.9
5.1
2.25
160
359
(3024561) Albumin [Mass/volume] in Serum or Plasma
467
2314
4.17
69.55
10.3
4.6
g/l
31.8
35.4
28.82
440
2128
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
368
1558
3.93
69.09
3.3
2.0
u/l
337.8
259.8
0.50
353
1463
(3002173) Hemoglobin [Mass/volume] in Arterial blood
195
522
4.82
69.04
14.7
8.0
g/l
114.7
121.6
4.28
187
504
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
523
2814
4.58
68.98
11.1
6.5
umol/l
12.3
12.1
0.10
506
2673
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
231
706
4.42
68.93
4.2
2.3
%
20.8
23.2
1.74
208
619
(3020682) Albumin/Creatinine [Ratio] in Urine
394
1760
3.90
67.98
6.4
3.8
mg/mmol
22.5
6.5
4.11
294
1116
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
382
1675
3.88
67.70
4.9
2.4
u/l
66.8
57.7
2.08
366
1547
(3022948) Iron [Moles/volume] in Serum or Plasma
248
821
4.16
66.01
4.2
2.3
umol/l
11.4
13.5
4.08
233
774
(3009508) Creatinine [Moles/volume] in Urine
387
1742
3.79
65.27
5.2
3.0
mmol/l
6.5
8.0
10.83
332
1458
(3012516) Albumin [Mass/volume] in Urine
376
1662
3.78
65.18
5.1
3.1
mg/l
118.1
292.1
1.12
293
1070
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
473
2442
4.00
64.45
17.3
5.6
mmol/l
1.2
1.2
13.94
451
2205
(3014576) Chloride [Moles/volume] in Serum or Plasma
224
701
4.26
64.22
14.0
6.4
mmol/l
104.2
104.6
0.52
214
689
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
495
2659
4.07
62.99
18.2
6.2
mmol/l
1.2
1.2
15.37
415
2256
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
322
1323
3.70
61.67
3.1
2.1
mg/l
3.5
3.1
1.31
282
1125
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
43
19
24.07
59.38
2.5
1.5
umol/l
102.7
40.2
0.87
20
12
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
244
866
3.82
57.71
2.4
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
150
385
4.70
55.06
10.5
4.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
88
139
7.11
54.64
1.7
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
123
271
5.31
54.15
13.5
9.5
mmol/l
21.8
24.5
4.83
111
255
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
135
331
4.83
52.29
6.4
3.6
ng/l
120.8
87.4
2.09
115
290
(3012501) Base excess in Blood by calculation
76
107
7.86
52.27
9.9
3.7
mmol/l
3.0
2.2
0.97
50
73
(3026008) Bacteria identified in Urine by Culture
326
1465
3.33
52.15
5.2
3.0
—
—
—
0
0
(3010421) pH of Blood
83
131
7.07
51.50
9.7
3.5
ph
7.4
7.4
6.82
74
106
(3036481) Cortisol [Moles/volume] in Serum or Plasma
150
418
4.31
49.17
2.3
2.2
nmol/l
397.2
360.0
1.00
135
384
(3013826) Glucose [Moles/volume] in Serum or Plasma
526
3228
3.67
48.40
14.0
4.5
mmol/l
8.2
6.7
19.60
518
3005
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
111
247
5.17
48.08
2.1
2.2
g/l
1.6
1.5
0.33
104
216
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
88
160
6.16
47.48
3.4
2.7
u/ml
0.3
0.3
0.55
52
91
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
339
1628
3.13
47.28
5.1
3.2
u/l
45.5
32.7
2.28
320
1543
(3019309) Folate [Moles/volume] in Red Blood Cells
255
1047
3.28
46.43
2.3
1.7
nmol/l
1298.7
1201.8
0.70
208
796
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
186
631
3.67
45.86
2.9
4.6
u/l
260.6
238.9
0.49
174
603
(3015235) Bicarbonate [Moles/volume] in Capillary blood
82
149
6.11
44.19
5.1
2.4
mmol/l
21.5
25.2
5.08
77
125
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
381
2016
2.99
43.66
5.8
3.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
107
251
4.86
43.38
2.4
2.0
ug/l
1.9
2.6
0.29
92
224
(3008152) Bicarbonate [Moles/volume] in Arterial blood
132
366
4.23
43.23
15.8
7.1
mmol/l
20.1
24.2
9.45
124
341
(3032080) INR in Blood by Coagulation assay
416
2323
3.00
42.92
18.0
9.5
inr
1.2
1.3
1.05
138
665
(40767503) Oxygen content in Capillary blood by calculation
70
114
6.72
42.00
5.0
2.2
%
16.1
16.6
0.27
43
59
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
176
607
3.55
41.97
2.6
1.9
%
1.9
1.5
3.47
148
521
(3022313) Gas panel - Capillary blood
112
282
4.55
41.53
7.8
3.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
384
2080
2.91
41.46
4.7
2.6
ug/l
207.3
160.8
1.29
354
1899
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
170
593
3.48
39.63
2.4
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
192
723
3.30
39.55
23.0
24.3
inr
1.3
1.4
0.23
25
112
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
169
590
3.47
39.32
2.3
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
310
1551
2.82
38.08
9.2
3.6
ph
7.4
7.4
3.76
82
302
(3028626) Oxygen [Partial pressure] in Capillary blood
77
152
5.58
37.90
5.9
3.5
kpa
8.5
8.3
0.35
72
135
(3027945) Reticulocytes/100 erythrocytes in Blood
178
658
3.30
37.61
2.8
2.8
%
2.0
1.7
2.04
161
596
(3024928) Oxygen saturation in Venous blood
63
104
6.57
37.23
5.1
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
63
107
6.38
36.20
5.4
2.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
163
593
3.29
35.15
4.4
2.7
umol/l
9.1
9.1
0.01
140
529
(3003181) Sodium [Moles/volume] in Urine
45
54
8.85
35.09
1.7
1.2
mmol/l
68.4
64.2
0.16
31
44
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
317
1663
2.68
34.68
3.8
2.9
ng/l
3647.1
1338.0
5.42
287
1425
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
385
2233
2.64
34.12
2.8
2.0
pmol/l
87.0
94.4
2.18
229
1156
(3042936) Bacteria identified in Isolate by Culture
198
820
2.99
34.04
2.4
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
247
1159
2.76
33.52
2.1
1.7
pmol/l
460.3
21414151.8
0.80
208
962
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
106
6.11
33.10
1.8
1.2
nmol/l
0.8
0.8
0.22
52
88
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
368
2115
2.59
32.84
7.3
3.4
ng/l
201.7
74.8
0.48
324
1546
(3022806) Fractional oxyhemoglobin in Capillary blood
48
70
7.30
31.76
3.2
1.3
%
87.2
89.3
0.80
48
70
(3023520) Reticulocytes [#/volume] in Blood
140
492
3.32
31.71
2.9
3.1
e9/l
68.3
69.3
0.13
121
384
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
93
249
4.16
31.52
5.9
2.6
%
0.7
0.7
0.33
93
241
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
135
467
3.35
31.35
4.8
2.5
u/l
42.9
43.2
0.01
122
401
(42870588) Differential panel, method unspecified - Blood
324
1794
2.52
30.71
7.3
6.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
109
338
3.64
29.93
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
334
1906
2.46
29.26
6.5
3.5
e6/l
87.8
104.9
0.18
273
1409
(3002582) Erythrocytes [#/volume] in Urine
306
1679
2.48
29.21
6.0
3.1
e6/l
41.2
117.4
1.15
270
1321
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
96
278
3.85
29.11
18.1
9.7
—
—
—
0
0
(3026782) Osmolality of Urine
225
1071
2.64
29.00
5.9
2.6
mosm/kgh2o
476.0
577.0
10.57
205
905
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
36
42
8.99
28.62
1.4
1.2
nmol/l
1.1
1.8
1.91
31
35
(3007853) Bacteria identified in Skin by Aerobe culture
157
632
2.92
27.86
2.4
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
501
3486
2.61
27.69
7.6
4.2
e6/l
30.4
2623.2
—
9
54
(3021960) Folate [Moles/volume] in Serum or Plasma
251
1288
2.49
27.35
2.0
1.5
nmol/l
20.1
20.5
0.11
217
1067
(3026493) Urate [Moles/volume] in Serum or Plasma
274
1470
2.44
27.01
3.9
2.7
umol/l
405.2
5820.5
4.79
233
1258
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
566
4209
2.94
26.89
15.2
7.4
u/l
93.4
79.0
6.93
551
3922
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
342
2029
2.36
26.74
3.3
2.1
nmol/l
68.4
77.7
7.05
317
1781
(3015377) Calcium [Moles/volume] in Serum or Plasma
316
1815
2.37
26.59
4.5
3.3
mmol/l
2.3
2.3
8.46
281
1571
(3020891) Body temperature
84
236
3.92
26.52
10.0
4.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
128
474
3.09
26.25
3.2
2.3
ug/l
7.8
7.3
0.12
110
424
(3019069) Monocytes/100 leukocytes in Blood
393
2491
2.35
26.13
8.1
6.3
%
8.9
8.9
0.00
372
2330
(3044640) Blood type and Crossmatch panel - Blood
297
1671
2.37
26.08
4.1
2.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
384
2412
2.34
26.05
7.8
6.0
%
0.7
0.7
0.00
362
2250
(3006315) Basophils [#/volume] in Blood
410
2653
2.35
25.88
7.2
5.9
e9/l
0.0
0.0
0.53
364
2291
(3006504) Eosinophils/100 leukocytes in Blood
390
2482
2.32
25.44
7.7
6.0
%
2.5
2.9
3.33
367
2312
(3002030) Lymphocytes/100 leukocytes in Blood
396
2538
2.32
25.38
8.0
6.1
%
23.3
27.8
11.85
372
2357
(3008295) Osmolality of Serum or Plasma
34
43
8.27
25.33
1.7
1.2
mosm/kgh2o
286.0
282.7
0.25
28
33
(3030467) Casts [#/volume] in Urine by Automated count
279
1553
2.34
24.84
5.9
3.0
e6/l
0.9
0.5
1.77
240
1192
(3001604) Monocytes [#/volume] in Blood
405
2639
2.30
24.69
7.1
5.9
e9/l
0.7
0.6
5.13
360
2275
(3047181) Lactate [Moles/volume] in Blood
64
157
4.39
24.19
12.4
6.1
mmol/l
2.6
1.2
2.90
56
136
(3019198) Lymphocytes [#/volume] in Blood
410
2706
2.27
23.95
7.2
5.9
e9/l
1.9
2.0
0.27
369
2386
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
60
141
4.57
23.94
5.5
4.9
mg/l
2.3
1.5
7.17
54
129
(3013650) Neutrophils [#/volume] in Blood by Automated count
448
3070
2.32
23.86
11.5
9.4
e9/l
4.9
4.1
7.97
407
2687
(3000570) Elastase.pancreatic [Mass/mass] in Stool
59
138
4.58
23.67
1.6
1.5
ug/g
260.6
269.5
0.09
34
82
(3000850) Epithelial cells [#/volume] in Urine
228
1183
2.39
23.65
5.3
2.4
e6/l
5.4
4.2
0.99
209
1041
(3013115) Eosinophils [#/volume] in Blood
411
2733
2.25
23.33
7.6
6.1
e9/l
0.2
0.2
0.05
366
2412
(3020630) Protein [Mass/volume] in Serum or Plasma
122
469
2.95
23.26
2.5
2.6
g/l
65.2
66.8
1.04
116
434
(3018010) Neutrophils/100 leukocytes in Blood
385
2501
2.22
23.06
7.7
5.9
%
61.0
57.0
7.61
362
2341
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
143
604
2.73
22.82
6.9
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
506
3688
2.41
22.79
7.6
4.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
266
1494
2.27
22.75
5.8
2.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
124
487
2.89
22.70
2.0
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
54
122
4.72
22.59
1.3
1.2
titre
55.0
128.3
—
6
6
(3033658) Prothrombin time (PT) actual/Normal
240
1308
2.28
21.91
9.0
3.8
%
82.3
87.3
2.05
232
1283
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
195
985
2.37
21.16
5.8
3.5
ng/l
405.0
464.2
0.12
171
795
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
473
3408
2.24
20.99
7.0
3.1
u/l
118.3
51.7
11.64
448
3146
(3037121) Protein [Mass/volume] in Urine
69
201
3.70
20.58
4.2
3.5
g/l
0.5
0.2
2.21
44
88
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
112
441
2.84
20.29
3.2
2.9
ng/l
413.7
198.9
2.10
103
405
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
379
2536
2.10
19.96
6.3
4.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
90
327
3.02
18.81
2.2
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
57
155
3.92
18.73
1.4
1.8
—
—
—
0
0
(4198724)
18
15
12.30
17.86
1.4
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
198
1077
2.18
17.54
2.1
1.7
mg/l
1.7
1.3
1.00
169
822
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
226
1297
2.11
17.41
3.9
2.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
99
397
2.74
17.21
2.1
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
122
545
2.51
17.04
2.1
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
52
142
3.88
16.98
2.9
2.4
ug/min
137.8
126.7
0.06
34
81
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
16
12
13.63
16.84
1.8
1.4
mmol/l
1.9
1.7
—
10
6
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
28
8.08
16.23
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
28
8.08
16.23
1.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
22
9
25.18
16.08
1.7
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
32
62
5.36
15.94
1.8
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
37
82
4.71
15.82
8.6
2.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
78
4.82
15.81
1.2
1.1
iu/ml
49.6
43.1
—
8
16
(3006922) Hepatitis E virus Ab [Presence] in Serum
22
29
7.80
15.77
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
58
181
3.41
15.54
2.3
3.4
mg/l
59.4
53.0
0.12
42
150
(3034860) Kappa light chains.free [Mass/volume] in Serum
58
181
3.41
15.54
2.3
3.4
mg/l
64.3
82.5
0.22
42
148
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
162
858
2.16
15.09
3.9
2.9
e6/l
1.5
1.4
0.12
109
488
(3035350) Ketones [Presence] in Urine by Test strip
368
2595
1.90
15.04
6.1
3.5
estimate
0.0
0.0
0.00
90
506
(40760888) Immunoglobulin light chains.free panel - Serum
47
132
3.75
14.74
2.5
3.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
71
260
2.93
14.56
1.7
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
52
159
3.46
14.38
1.7
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
98
428
2.50
14.25
10.9
3.3
mmol/l
1.2
1.2
3.74
93
375
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
26
47
5.71
13.92
1.2
1.3
pmol/l
304.8
289.0
0.08
17
38
(3035637) Corticotropin [Mass/volume] in Plasma
28
55
5.26
13.73
1.6
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
168
939
2.04
13.41
3.8
2.7
e6/l
1.2
1.0
0.37
115
562
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
42
5.88
13.28
1.1
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
147
3.44
13.24
1.3
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
38
99
4.00
13.23
1.8
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
20
29
7.07
13.20
2.8
5.6
%
9.8
12.1
1.48
20
29
(3042733) HLA Ab [Presence] in Serum
15
15
10.20
13.17
5.7
5.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
74
4.49
12.99
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
43
5.75
12.97
1.4
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
211
1292
1.91
12.88
8.1
7.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
129
664
2.16
12.75
2.2
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
84
4.21
12.70
1.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
40
112
3.73
12.61
2.6
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
360
2613
1.79
12.56
6.1
3.5
estimate
0.0
0.0
0.00
84
489
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
61
223
2.90
12.53
2.1
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
9
20.49
12.51
2.1
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
41
119
3.60
12.27
2.5
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
42
5.63
12.19
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
50
5.15
12.02
3.3
3.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
91
417
2.36
11.85
2.5
2.8
g/l
11.6
10.8
0.59
84
387
(3028300) Cannabinoids [Presence] in Urine
41
122
3.51
11.82
2.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
47
5.25
11.81
1.4
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
109
3.63
11.57
1.3
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
352
2580
1.75
11.51
8.0
4.7
estimate
0.0
0.0
0.00
89
510
(3027944) Amphetamines [Presence] in Urine
40
120
3.48
11.39
2.5
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
13
10.17
11.37
1.9
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
70
4.28
11.17
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
40
122
3.42
11.11
2.6
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
34
95
3.71
10.76
2.5
4.5
%
2.1
0.8
0.90
25
80
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
44
146
3.15
10.69
1.3
1.8
—
—
—
0
0
(3019977) pH of Arterial blood
18
30
6.13
10.43
3.0
4.3
ph
7.4
7.4
—
7
13
(3028026) IgM [Mass/volume] in Serum or Plasma
74
327
2.42
10.42
1.6
1.7
g/l
1.2
1.5
0.48
69
302
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
93
3.68
10.32
1.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
66
4.22
10.24
1.4
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
39
124
3.27
10.16
1.6
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
95
3.60
10.01
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
53
203
2.75
9.99
2.2
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
31
86
3.73
9.92
2.8
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
116
3.31
9.86
2.5
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
32
5.75
9.79
1.2
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
187
1187
1.79
9.78
5.0
3.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
40
5.12
9.62
1.2
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
26
6.28
9.49
1.1
1.0
nmol/l
154.2
132.9
0.85
16
26
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
33
5.57
9.49
1.2
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
104
3.39
9.42
1.2
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
13
17
7.78
9.30
2.8
2.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
118
3.16
8.94
1.2
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
92
481
2.05
8.59
8.6
3.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
89
460
2.07
8.57
4.3
4.5
%
0.7
0.8
0.21
35
156
(3029937) Albumin [Presence] in Urine by Test strip
220
1509
1.67
8.53
6.7
3.7
estimate
0.0
0.0
0.00
78
490
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
36
122
3.06
8.47
2.5
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
12
16
7.62
8.43
1.9
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
113
640
1.92
8.40
1.4
1.3
titre
534.7
452.3
0.18
19
146
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
162
1030
1.75
8.26
4.0
3.1
mmol/l
2.5
2.4
1.94
145
898
(21494890) Protein electrophoresis panel - 24 hour Urine
23
59
4.00
8.21
1.3
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
174
1134
1.72
8.11
5.2
4.8
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
24
5.93
7.88
2.9
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
319
2433
1.58
7.87
20.4
9.3
e9/l
0.0
0.0
0.13
272
2001
(3021879) Hepatitis B virus core Ab [Presence] in Serum
66
316
2.20
7.72
1.7
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
113
3.02
7.64
1.6
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
104
3.07
7.44
1.7
1.3
u/ml
278.1
254.4
0.15
14
59
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
34
121
2.90
7.37
2.2
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
23
64
3.68
7.35
1.6
1.4
e6/l
2489.5
1366.1
0.26
17
49
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
70
3.52
7.17
1.7
5.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
26
80
3.34
7.17
1.5
1.5
g/l
28.7
33.1
0.81
20
74
(3021440) Promyelocytes/100 leukocytes in Blood
81
433
1.99
7.10
4.5
4.6
%
0.1
0.1
0.38
30
141
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
98
3.05
6.88
1.8
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
78
417
1.98
6.83
4.0
4.5
%
0.5
0.3
0.29
23
115
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
111
2.88
6.66
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
111
2.88
6.66
1.5
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
21
59
3.64
6.63
1.6
1.4
e6/l
21076.1
68232.1
0.61
14
37
(3014271) Vancomycin [Susceptibility]
12
21
5.80
6.60
3.5
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
599
5413
1.82
6.56
42.6
13.7
mg/l
29.0
26.1
1.36
574
4259
(3013512) EKG study
234
1717
1.55
6.54
6.4
3.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
55
3.72
6.51
1.6
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
25
5.28
6.51
2.3
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
33
4.62
6.48
2.1
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
33
4.62
6.48
1.7
3.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
33
4.62
6.48
2.1
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
14
30
4.74
6.23
1.1
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
21
62
3.46
6.18
2.3
2.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
29
106
2.81
6.02
2.8
1.4
u/ml
118.4
147.3
—
10
17
(3007164) IgA [Mass/volume] in Serum or Plasma
141
939
1.63
5.88
2.1
1.4
g/l
3.5
2.7
1.97
97
550
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
24
80
3.07
5.85
1.7
2.6
pg
32.9
32.6
0.08
24
80
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
91
2.93
5.84
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
32
4.45
5.79
1.8
3.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
34
138
2.54
5.78
1.3
1.7
—
—
—
0
0
(3019225) pH of Specimen
93
556
1.78
5.76
10.0
3.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
157
2.43
5.74
1.7
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
86
503
1.81
5.73
5.5
3.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
46
3.76
5.67
1.8
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
98
599
1.74
5.63
4.4
4.4
ug/l
5.6
33.0
1.26
84
501
(3022493) Free Hemoglobin [Mass/volume] in Plasma
12
25
4.87
5.51
1.0
1.7
mg/l
52.2
53.7
0.04
12
20
(3052851) Hemolysis interference index of Serum or Plasma
38
167
2.35
5.47
7.6
3.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
36
155
2.40
5.42
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
73
3.08
5.42
2.5
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
63
3.24
5.35
1.4
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
48
3.61
5.35
1.6
1.5
nmol/l
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
18
53
3.46
5.34
1.2
1.3
%
12.4
30.3
1.99
11
36
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
8
11.38
5.30
6.9
5.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
72
411
1.84
5.20
4.7
4.6
%
0.0
0.8
0.60
26
121
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
75
3.00
5.18
2.5
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
75
3.00
5.18
2.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
263
2053
1.45
5.18
7.2
3.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
450
3881
1.46
5.18
4.4
3.5
pmol/l
14.8
14.9
0.74
400
3463
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
6
13.47
5.09
6.4
6.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
460
3992
1.46
5.07
5.1
3.9
mm/h
22.4
12.4
17.79
426
3648
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
9
10.11
5.03
7.0
5.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
9
10.11
5.03
1.8
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
66
3.09
4.98
2.5
4.7
%
70.0
50.9
—
9
49
(4146454)
17
51
3.39
4.91
3.2
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
397
0.29
4.90
1.1
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
10
20
5.06
4.79
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
20
5.06
4.79
1.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
27
108
2.56
4.76
3.1
3.2
%
61.4
56.7
0.94
27
108
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
79
2.84
4.75
1.2
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
164
1184
1.51
4.73
5.8
3.7
kg/l
1.0
1.0
0.72
26
169
(40768797) Stomach Pathology biopsy report
114
761
1.60
4.66
1.4
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
53
3.26
4.64
1.2
1.2
u/l
69.5
56.5
0.26
11
35
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
207
2.10
4.63
2.0
2.2
g/l
3.3
3.2
0.21
33
166
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
75
2.86
4.59
2.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
75
2.86
4.59
2.4
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
76
2.82
4.48
2.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
143
2.30
4.47
1.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
65
2.98
4.47
2.2
1.9
u/l
5100.7
3322.4
—
8
23
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
30
4.05
4.45
2.3
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
30
4.05
4.45
2.3
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
144
2.28
4.41
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
144
2.28
4.41
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
535
4832
1.48
4.39
5.6
4.2
mu/l
2.1
2.0
0.95
493
4323
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
39
191
2.10
4.38
2.6
2.4
g/l
0.9
2.0
0.55
34
172
(3049717) Cytology report of Urine Cyto stain
49
263
1.93
4.29
3.6
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
427
0.36
4.29
1.4
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
143
1023
1.50
4.28
1.4
1.2
u/ml
1.2
1.8
0.53
34
275
(3004451) EKG impression Narrative
12
31
3.92
4.27
1.7
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
56
3.09
4.26
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
56
3.09
4.26
1.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
56
3.09
4.26
1.2
1.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
128
2.32
4.18
3.3
2.9
nmol/l
0.8
0.9
0.18
21
99
(3021788) Differential panel - Synovial fluid
25
104
2.46
4.10
1.2
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
47
3.24
4.07
1.8
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
218
1.99
4.06
2.0
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
218
1.99
4.06
2.0
2.2
g/l
7.6
7.4
0.23
33
169
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
218
1.99
4.06
2.0
2.2
g/l
3.8
3.8
0.03
33
162
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
563
5162
1.50
4.05
11.5
5.6
mmol/mol
48.0
39.8
32.30
533
4727
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
278
0.31
4.04
1.1
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
7
7
10.09
4.01
1.9
1.3
mmol/l
1.2
1.2
—
7
7
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
14
6.50
3.99
1.6
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
36
180
2.06
3.86
2.1
2.2
g/l
33.2
37.2
2.40
31
157
(3013727) Leukocytes other/100 leukocytes in Blood
9
15
6.06
3.82
2.7
4.0
%
47.1
45.8
—
9
15
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
15
6.06
3.82
4.2
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
15
6.06
3.82
4.2
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
29
3.84
3.81
1.5
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
7
8
8.82
3.78
1.9
1.4
mmol/l
1.2
1.2
—
7
8
(3041096) Erythrocytes [Presence] in Urine by Automated
183
1407
1.41
3.71
6.6
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
103
2.38
3.70
3.3
2.9
e9/l
4.9
4.2
0.79
24
103
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
40
214
1.92
3.57
1.4
1.9
u/l
46.1
40.8
0.80
35
188
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
26
3.89
3.53
25.7
18.0
nmol/l
1838.3
1489.5
—
10
26
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
26
3.89
3.53
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
203
1.92
3.42
2.1
2.2
g/l
10.3
11.3
0.50
33
176
(3000475) Leukocytes [#/volume] in Synovial fluid
29
141
2.10
3.37
1.8
1.7
e6/l
19738.6
16700.7
0.13
21
101
(3042631) Mycobacterium sp identified in Specimen
21
89
2.40
3.35
2.0
2.4
—
—
—
0
0
(4024509)
14
48
2.96
3.31
1.8
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
7
8.63
3.27
3.7
8.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
70
455
1.60
3.21
4.7
2.6
ml/min/173m2
43.5
65.4
4.04
42
168
(3000494) Fungus identified in Specimen by Culture
94
655
1.50
3.18
1.6
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
80
2.41
3.08
1.8
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
15
57
2.67
2.98
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
57
2.67
2.98
1.2
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
80
548
1.52
2.94
2.3
2.3
ug/g
165.9
123.6
0.63
68
432
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
17
4.75
2.92
1.1
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
17
4.75
2.92
2.3
5.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
58
2.62
2.89
1.1
1.7
%
77.6
59.8
—
7
39
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
9
6.71
2.87
4.2
13.7
mmol/l
4.6
6.8
—
6
9
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
38
216
1.80
2.86
3.1
3.6
u/ml
442.0
5694.0
0.57
33
178
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
26
130
2.04
2.84
1.2
1.6
e6/l
1.0
29.9
0.64
20
101
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
18
4.48
2.80
1.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
66
2.46
2.72
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
12
43
2.82
2.65
1.2
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
10
32
3.16
2.65
2.2
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
183
1478
1.32
2.63
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
107
2.09
2.60
1.2
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
74
2.33
2.59
1.2
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
68
2.39
2.57
1.1
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
68
2.39
2.57
4.3
2.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
16
68
2.39
2.57
1.5
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
81
2.26
2.56
1.3
1.7
g/l
0.6
0.9
0.88
13
64
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
134
1696
0.74
2.53
2.4
3.1
ug/l
0.8
0.7
0.69
97
1163
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
12
5.03
2.40
1.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
139
1.90
2.39
1.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
118
1.98
2.38
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
52
2.53
2.37
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
22
3.67
2.37
1.1
1.2
—
—
—
0
0
(4062490)
12
46
2.64
2.37
1.2
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
606
5770
1.42
2.34
55.1
15.7
mmol/l
138.6
139.8
20.89
599
5603
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
554
0.59
2.33
1.4
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
153
1877
0.76
2.29
4.5
2.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
156
1.83
2.29
2.7
1.5
iu/ml
0.1
40.1
—
7
30
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
12
47
2.58
2.28
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
47
2.58
2.28
1.2
1.3
g/l
12.2
7.9
—
7
33
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
47
2.58
2.28
1.2
1.3
g/l
0.3
0.4
—
7
32
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
47
2.58
2.28
1.2
1.3
g/l
2.3
3.0
—
6
34
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
13
4.65
2.27
1.0
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
607
5791
1.41
2.22
54.7
15.8
mmol/l
4.1
4.0
4.87
598
5613
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
329
2911
1.25
2.22
3.2
2.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
9
5.59
2.21
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
9
5.59
2.21
3.8
2.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
36
2.80
2.21
2.1
3.0
—
—
—
0
0
(4281824)
12
48
2.53
2.19
1.3
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
433
3955
1.26
2.19
5.8
3.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
19
3.71
2.15
1.1
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
19
3.71
2.15
1.3
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
14
4.31
2.15
1.2
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
30
3.03
2.15
1.1
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
30
3.03
2.15
1.1
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
30
3.03
2.15
1.1
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
30
3.03
2.15
1.1
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
55
2.39
2.13
1.5
2.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
55
2.39
2.13
1.2
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
116
1.93
2.13
1.4
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
84
621
1.40
2.12
1.5
1.3
—
—
—
0
0
(44790047)
16
75
2.16
2.10
1.2
1.6
—
—
—
0
0
(44806118)
16
75
2.16
2.10
1.2
1.6
—
—
—
0
0
(44790049)
16
75
2.16
2.10
1.2
1.6
—
—
—
0
0
(44790048)
16
75
2.16
2.10
1.2
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
178
0.39
2.05
1.7
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
50
2.42
2.03
1.6
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
90
2.03
2.02
1.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
38
2.66
2.01
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
38
2.66
2.01
1.5
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
218
1.64
1.98
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
21
3.36
1.97
2.4
3.6
—
—
—
0
0
(4035726)
68
494
1.42
1.91
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
46
2.41
1.86
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
59
2.23
1.85
2.2
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
59
2.23
1.85
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
17
3.55
1.84
1.0
1.0
miu/ml
2015.8
1271.2
—
6
17
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
20
108
1.88
1.83
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
35
2.59
1.80
1.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
29
2.78
1.79
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
334
0.56
1.77
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
30
2.69
1.73
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
96
1.90
1.72
1.4
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
48
2.31
1.71
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
201
2313
0.81
1.66
3.6
4.3
%
22.9
21.2
0.96
103
1192
(44806420)
6
19
3.18
1.66
2.0
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
135
1.73
1.64
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
230
1.55
1.63
2.7
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
14
3.59
1.62
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
14
3.59
1.62
2.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
91
1.89
1.61
1.2
2.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
32
2.52
1.60
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
32
2.52
1.60
2.1
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
173
0.46
1.60
1.5
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
10
44
2.29
1.53
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
27
2.61
1.52
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
51
2.18
1.51
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
58
2.09
1.50
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
37
2.45
1.48
1.1
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
45
2.24
1.47
2.3
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
38
263
1.47
1.42
8.7
3.7
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
10
46
2.19
1.40
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
591
5693
1.27
1.39
40.7
13.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
53
2.09
1.39
1.5
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
38
266
1.45
1.35
2.4
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
40
283
1.44
1.35
2.8
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
105
1.73
1.34
1.1
1.2
—
12.7
—
0
7
(40768441) Liver Pathology biopsy report
9
42
2.16
1.34
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
52
686
0.74
1.31
1.6
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
262
1.44
1.25
1.2
1.2
iu/ml
127.7
144.8
0.14
13
105
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
37
2.18
1.21
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
37
2.18
1.21
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
509
4854
1.19
1.19
39.4
14.6
%
36.6
40.2
11.89
278
3301
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
224
1.45
1.16
1.9
3.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
1.8
1.4
ug/l
1.9
3.3
—
5
15
(3029075) Extractable nuclear Ab panel - Serum
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
(4034850)
26
176
1.50
1.12
12.9
10.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
352
1.33
1.02
3.2
3.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
115
1.58
1.00
3.9
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
84
1.68
0.98
1.6
1.6
iu/l
3.9
5.1
—
8
23
(40765096) Chromosome analysis panel by Banding
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
184
0.59
0.94
2.4
1.7
nmol/l
36.6
42.4
0.50
11
177
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
27
2.23
0.93
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
27
2.23
0.93
1.3
1.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
29
2.08
0.89
1.2
1.2
u/l
78.2
104.0
—
6
22
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
6
29
2.08
0.89
1.2
1.2
u/l
13.8
23.6
—
6
22
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
42
1.92
0.88
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
87
736
1.21
0.87
18.4
6.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
170
1.43
0.86
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
162
1.43
0.85
1.3
2.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
141
0.56
0.83
3.0
1.8
pmol/l
149.5
229.5
—
8
129
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
65
1.70
0.82
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
20
140
1.44
0.77
1.1
1.2
—
1.3
—
0
5
(3002385) Erythrocyte distribution width [Ratio]
464
4455
1.13
0.77
47.2
16.6
%
14.8
13.7
27.23
456
4349
(3024263) Appearance of Synovial fluid
6
34
1.77
0.76
1.5
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
54
1.68
0.74
1.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
39
1.80
0.72
12.7
2.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
46
372
1.25
0.72
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
60
1.68
0.72
11.1
2.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
182
0.65
0.71
1.3
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
26
1.93
0.70
1.4
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
41
1.71
0.70
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
28
1.79
0.66
1.0
19.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
70
1.58
0.65
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
466
0.80
0.62
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
96
1.47
0.62
1.4
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(4094501)
9
140
0.64
0.61
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
596
5842
1.15
0.60
21.7
10.2
u/l
33.2
26.7
1.23
584
5596
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
74
1.49
0.53
1.3
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
270
2847
0.92
0.53
4.5
5.0
ug/l
3.3
3.1
0.08
236
2543
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
6
40
1.50
0.51
1.2
1.5
—
13.0
—
0
18
(3045142) Bone marrow Pathology biopsy report
10
69
1.46
0.44
1.1
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
151
0.72
0.43
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
31
1.62
0.43
1.8
3.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
1.4
g/l
0.7
1.0
—
5
31
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.1
—
103.1
—
0
9
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.1
—
99.2
—
0
9
(40758292) HTLV I+II Ab panel - Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
111.4
—
0
16
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
799
0.89
0.40
1.3
1.2
u/ml
10.3
13.3
0.28
22
301
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
102
0.68
0.39
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
61
1.32
0.39
1.3
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
529
5390
0.92
0.39
5.7
4.3
mmol/l
1.3
1.4
7.56
484
4885
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
312
0.83
0.38
1.3
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
200
2106
0.93
0.37
2.3
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
135
1.27
0.35
1.8
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
127
1.27
0.33
1.7
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
87
0.69
0.33
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
78
715
1.10
0.32
1.5
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
371
1.14
0.31
3.2
2.9
e9/l
3.9
4.0
0.09
29
278
(3000492) Spirometry study
54
486
1.12
0.31
1.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
535
5429
0.93
0.29
5.7
4.4
mmol/l
4.1
4.6
22.82
489
4967
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
214
1.17
0.28
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
67
1.20
0.26
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
141
1.21
0.26
14.4
4.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
75
0.66
0.26
1.6
1.5
—
—
—
0
0
(1002224) Polysomnography panel
16
190
0.84
0.23
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
79
1.27
0.22
1.5
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
545
5387
1.06
0.21
6.7
4.6
mmol/l
7.3
6.0
23.41
500
4830
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
530
5235
1.05
0.21
39.0
12.5
ml/min/173m2
66.3
78.9
16.88
480
4347
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
2.8
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
13
0.00
0.21
0.0
1.5
—
7.9
—
0
6
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.8
—
6.0
—
0
13
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
82
1.22
0.17
1.7
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
63
1.11
0.17
1.1
1.2
—
—
—
0
0
(4306422)
5
68
0.73
0.17
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
68
1.18
0.16
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
119
0.84
0.15
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
146
1505
0.96
0.14
2.0
1.6
mmol/l
1.8
1.3
3.01
119
1224
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
80
835
0.95
0.13
1.3
1.3
iu/ml
51.1
36.7
0.17
27
261
(40768443) Skin Pathology biopsy report
22
242
0.91
0.13
1.4
1.3
—
—
—
0
0
(4010399)
38
405
0.93
0.12
1.3
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
105
1.15
0.11
1.5
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
136
0.88
0.11
1.3
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
47
1.06
0.09
1.2
1.0
ng/l
679.4
620.7
—
5
25
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
551
5541
0.97
0.09
6.2
4.9
mmol/l
2.2
2.7
39.77
503
5013
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
11
97
1.14
0.09
1.1
1.2
—
17.3
—
0
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
64
0.78
0.08
3.0
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
293
1.06
0.08
2.5
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
523
5203
1.02
0.07
5.4
3.9
mmol/l
1.6
1.3
8.38
475
4700
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
85
1.06
0.07
1.4
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
74
722
1.03
0.05
5.6
4.3
%
33.3
31.4
0.72
59
477
(3000963) Hemoglobin [Mass/volume] in Blood
608
6097
0.98
0.05
58.2
20.4
g/l
122.9
136.9
64.34
601
5971
(3017446) Testosterone [Moles/volume] in Serum or Plasma
52
533
0.97
0.04
2.5
2.2
nmol/l
10.1
13.8
2.20
42
478
(3026361) Erythrocytes [#/volume] in Blood
608
6094
0.98
0.03
57.6
20.3
e12/l
4.1
4.5
47.03
598
5870
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
141
1.07
0.03
1.4
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
608
6093
0.98
0.03
57.3
20.2
fl
92.7
91.4
6.83
601
5973
(3035941) MCH [Entitic mass]
608
6093
0.98
0.03
57.3
20.2
pg
30.5
30.5
0.28
601
5971
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
31
320
0.97
0.03
2.5
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
608
6091
0.98
0.02
57.6
20.3
e9/l
247.4
240.6
1.29
599
5894
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
116
0.95
0.00
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
609
6095
0.99
0.00
57.5
20.3
e9/l
7.9
6.7
5.48
598
5876
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
25.3
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
73
0.96
0.00
1.3
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
73
0.96
0.00
1.7
3.3
u/ml
16.4
30.0
—
7
73
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
17.9
—
0
7
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
2.2
—
1.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint E4_ACIDOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ACIDOSIS | 4.343 [3.3, 5.71] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.601 |
During the follow-up period (1.1.1998 — 31.12.2019), 482 out of 1194 females with E4_ACIDOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ACIDOSIS | 5.206 [4.09, 6.63] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 864 out of 2128 males with E4_ACIDOSIS died.
Mortality risk
Mortality risk for people of age
years, who have E4_ACIDOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.48% | 0.771% |
| 5 | 2.92% | 5.339% |
| 10 | 6.434% | 13.916% |
| 15 | 12.782% | 25.455% |
| 20 | 22.326% | 39.972% |
Relationships between endpoints
↥Index endpoint: E4_ACIDOSIS – Acidosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data